Voxelotor (GBT440), a First-In-Class Hemoglobin Oxygen-Affinity Modulator, Has Promising and Reassuring Preclinical and Clinical Data
American Journal of Hematology - United States
doi 10.1002/ajh.25042
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 7, 2018
Authors
Publisher
Wiley